Gleneagle Gold Limited provided an update on behalf of Zelda Therapeutics Pty Ltd. has appointed distinguished medical clinician, Dr. Joe Goldstrich, to the company's Scientific Advisory Board with immediate effect. Dr. Goldstrich has a distinguished clinical career in preventive cardiology and nutrition spanning over 40 years. His work includes roles as the National Director of Education and Community Programs for the prestigious American Heart Association, Medical Director at the Pritikin Longevity Center and Medical Director of ProCaps Laboratories, where he designed nutritional supplements based on published scientific studies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 AUD | -2.22% | -2.22% | -51.11% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.11% | 3.3M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Joe Goldstrich Joins Zelda Therapeutics Scientific Advisor Board